Opioids Market 2019 Global Opportunities and Industry Share Expected Surpass US$ 51,005.8 Million by 2027 – Latest Application Development Insights
Opioids are classified as narcotics, which act on opioid receptors to produce morphine effects. They are primarily used in pain management and treatment of diarrhea and cough. They can be classified as agonist and antagonist drugs. Agonist include Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone whereas antagonist include Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified under antagonists.
For Any Queries Get Solutions With PDF Sample: https://www.coherentmarketinsights.com/insight/request-pdf/1017
Opioids are overused globally, because of its easy availability and the situation is more critical in developed economies such as the U.S. This has led to the government or regulatory intervention in sales and prescription of opioids in various countries such as U.S., Canada, Germany, and India. The prescription pattern of this drug is closely monitored by U.S. FDA. Moreover, for prescribed opioids, stringent guidelines are formed by regulatory bodies with public awareness about drug dependency caused by the drug because it is widely used by the patient. Furthermore, government bodies have directed drug-stores to reduce opioid delivery and participate in government activities addressing the opioid crisis.
The number of opioid prescriptions has increased significantly in the last two decades, worldwide. However, the rate of prescription is much high in the U.S. and this can be attributed to the high prevalence of chronic pain and other related diseases. Moreover, the majority of these prescription drugs in the U.S. are misused or abused by the patients. According to results from the 2017 National Survey on Drug Use and Health, an estimated 2 million Americans misused prescription pain relievers in the within the past year, which averages to approximately 5,480 initiates per day.
Quick Buy – Opioids Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1017
The global opioids market is estimated to account for US$ 51,005.8 Mn in terms of value by the end of 2027 and is expected to witness a CAGR of 2.9% over the forecast period (2019 –2027).
Rising incidence of chronic pain is projected to fuel the global opioids market growth
Growing incidence of chronic pain across emerging economies such as the U.S., the U.K., Germany, and Canada. According to a study published by BMJ (British Medical Journal), in 2013, around one-third to one-half of the population in the U.K. suffered from chronic pain. According to a study published in NCBI, in 2015, the prevalence of chronic pain is estimated to be as high as 20% (one in five) in Japan. Rapidly growing geriatric population base rate in developed economies is also projected to increase the consumption of opioid drugs.
Market – Restraints
Side-effects associated with the consumption of opioids such as vomiting, and dizziness, as well as addiction, is projected to hamper the market growth. A poll conducted by the New England Journal of Medicine in 2013 found that 75% (3 out of 4) clinicians in the U.S. recommended the use of cannabis for hypothetical cancer patients. Thus, the availability of cannabis as an alternative to opioids is expected to hamper the growth of the global opioids market over the forecast period.
Regional Insights
On the basis of region, the global opioids market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The growing prevalence of cancer in the U.S. is expected to increase demand for opioids to treat cancer pain. According to the National Cancer Institute, cancer-related pain occurs in 20% to 50% of cancer patients. Furthermore, around 80% of patients with advanced-stage cancer have moderate to severe pain.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/global-opioids-market-to-surpass-us-426-billion-threshold-by-2024-442
Some of the opioid brands used for pain management in the U.S. include Tramadol (Ultram), Hydromorphone (Dilaudid), Methadone (Dolophine and Methadose), Morphine (Apokyn, Avinza, Kadian, MS-Contin, and others), and Oxycodone (OxyContin, OxyIR, and Roxicodone).
Competitive Landscape
Key players operating in the global opioids market include Purdue Pharma L.P, Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc, Allergan Plc, Pfizer Inc, and Sun Pharmaceutical Industries Ltd.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippets, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- Global Opioids Market, By Product Type, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Introduction
- Global Opioids Market, By Application, 2019 – 2027, (US$ Mn)
- Analgesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Cough Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Diarrhea Suppression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Analgesia
- Global Opioids Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
